Beam Therapeutics Inc.
BEAM$32.83▲ 11.10% 24h
Beam Therapeutics Inc.BEAM$32.83
+$20.03(+156.53%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$3.34B
P/E ratio
—
EPS (diluted)
$-0.81
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$139.74M
Net income
$-79.99M
Net margin
-57.2%
Gross margin
—
Dividends & financials
Beam Therapeutics Inc. (BEAM) reported revenue of $139.74M and net income of $-79.99M, or $-0.81 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.